Hopp til hovedinnhold

Diabetisk nevropati

Sist oppdatert: Sist revidert:
Sist revidert av:
Definisjon: 
Er nerveskade på grunn av diabetes. Vanligst er distal symmetrisk polynevropati og autonom nevropati
Forekomst: 
Prevalens øker med alderen fra 5% tidlig i forløpet til nærmere 50% etter minst 25 år med sykdommen. Noe hyppigere ved type 2 enn ved type 1-diabetes
Symptomer: 
Tidlige symptomer kan være nummenhet, stikking, prikking, brennende/verkende smerte eller ømhet på leggene eller i føttene
Funn: 
Kan være nedsatt følesans, vibrasjonssans, smerte i føttene
Diagnostikk: 
Monofilament-test, vibrasjonssans, ankelrefleks. Ev. nevrografi
Behandling: 
God blodsukkerkontroll. Forebygging og behandling av fotsår. Adekvat smertebehandling + tiltak mot andre risikofaktorer
  1. Helsedirektoratet. Nasjonale faglig retningslinje for diabetes. Sist faglig oppdatert: 16. mars 2021. helsedirektoratet.no  
  2. Malik RA, Alam U, Azmi S. Diabetic neuropathy. BMJ Best Practice, last updated June 2019.
  3. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-54. PubMed  
  4. Callaghan BC, Cheng HT, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-34. PubMed  
  5. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):42. Published 2019 Jun 13. PMID: 31197183 PubMed  
  6. Mizrak HI, Hansen TW, Rossing P, et al. Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes. Diabetes Care 2023; 46: 1997-2003. pmid:37647323 PubMed  
  7. Snyder MJ, Gibbs LM. Treating painful diabetic peripheral neuropathy: an update. Am Fam Physician 2016; 94: 227-34. American Family Physician  
  8. Garces-Sanchez M, Laughlin RS, Dyck PJ, et al. Painless diabetic motor neuropathy: A variant of diabetic lumbosacral radiculoplexus neuropathy?. Ann Neurol 2011; 69: 1043-54. PubMed  
  9. Agashe S, Petak S. Cardiac Autonomic Neuropathy in Diabetes Mellitus. Methodist Debakey Cardiovasc J. 2018;14(4):251-256. PubMed  
  10. Fan J, Peng T, Hui J, et al. Erectile Dysfunction in Type-2 Diabetes Mellitus Patients: Predictors of Early Detection and Treatment. Urol Int. 2021;105(11-12):986-992. PMID: 33951654 PubMed  
  11. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014;37:S14-S80.
  12. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012; :CD007543. Cochrane (DOI)  
  13. Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938-948. PubMed  
  14. Griebeler ML, Morey-Vargas OL, Brito JP, et al. Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med 2014; 161: 639-49. doi:10.7326/M14-0511 DOI  
  15. Tesfaye S, Sloan G, Petrie J, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 2022. pmid:36007534 PubMed  
  16. Price R, Smith D, Franklin G, et al. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee. Neurology. 2022;98(1):31-43. PubMed  
  17. Ziegler D, Fonseca V. From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. J Diabetes Complications. 2015;29(1):146–156.
  18. Griebeler ML, Morey-Vargas OL, Brito JP, et al. Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis published corrections appear in Ann Intern Med. 2015;162(8):600, and Ann Intern Med. 2015;162(10)739. Ann Intern Med. 2014;161(9):639–649.
  19. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;1:CD007115. PMID: 24385423 PubMed  
  20. Kaur H, Hota D, Bhansali H, et al. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: A randomized, double-blind, cross-over clinical trial. Diabetes Care 2011; 34: 818-22. PubMed  
  21. Waldfogel JM, Nesbit SA, Dy SM, et al. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life. Neurology 2017. doi:10.1212/WNL.0000000000003882 DOI  
  22. Jingxuan L, Litian M, Jianfang F. Different Drugs for the Treatment of Painful Diabetic Peripheral Neuropathy: A Meta-Analysis. Front Neurol. 2021;12:682244. Published 2021 Oct 29. PMID: 34777192 PubMed  
  23. Ko SH, Kwon HS, Yu JM, et al. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy. Diabet Med 2010; 27: 1033-40. PubMed  
  24. Tesfaye S, Wilhelm S, Lledo A, et al. Duloxetine and pregabalin: High-dose monotherapy or their combination? The ``COMBO-DN study`` - a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain 2013. doi:10.1016/j.pain.2013.05.043 DOI  
  25. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD006146. DOI: 10.1002/14651858.CD006146.pub2. DOI  
  26. Vinik AI, Shapiro DY, Rauschkolb C, et al. A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy. Diabetes Care. 2014;37(8):2302–2309.
  27. Simpson DM, Robinson-Papp J, Van J, et al. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. J Pain. 2017; 18: 42-53. PMID: 27746370 PubMed  
  28. Nøkleby K, Julsrud Berg T. Diabetisk nevropati - en klinisk oversikt. Tidsskr Nor Lægeforen 2005; 125: 1646-9. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Tor Claudi, spesialist i allmennmedisin og indremedisin, Rønvik legesenter, Bodø og NOKLUS-klinikk, Bergen
  • Lino Witte, Dr. med., Arzt in Weiterbildung, innere Medizin, Frankfurt, Tyskland (Deximed.de)